Limited Profile - Effipharma

Posted By: Justin Brown (University of North Carolina)

Key Team Members: Alan Dow, Richard Mailman, Justin Brown, Todd Johnson

Brief Description: Effipharma, Inc. is a life science company engaged in the discovery and development of novel therapeutics for the treatment of multiple central nervous system disorders. The company seeks to develop first-in-class therapeutics by leveraging expertise in areas of demonstrated clinical importance. Effipharma currently has multiple preclinical product candidates for the treatment of Parkinson's disease, Alzheimer's disease, schizophrenia and other deficits of cognition.

Featured Business: